Concentrations of ceftazidime and avibactam in bile fluid—a prospective phase IIb study
The concentrations of CAZ and AVI in bile suggest their potential as a valuable therapeutic option for multi-resistant biliary infections.
Authors
- Tim Rahmel (ORCID: https://orcid.org/0000-0002-7039-6288)
- Lars Palmowski
- Christoph Dorn (ORCID: https://orcid.org/0000-0002-2560-9598)
- Iris K. Minichmayr (ORCID: https://orcid.org/0000-0002-2679-8589)
- Andrea Witowski
- Michael Adamzik (ORCID: https://orcid.org/0000-0002-7188-4873)
- Hartmuth Nowak (ORCID: https://orcid.org/0000-0002-6509-1463)
- Constantin Lier
- Markus Zeitlinger
Institutions
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- University of Regensburg (DE)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1093/jac/dkae361
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Pfizer